shut down, in some cases, doctors stopped performing what had been routine medical care out of fear of litigation or imprisonment, leaving some women with life altering conditions and scarring, both physical and emotional. on the broad end, more than 25 million women of child bearing age from 14 to 44 live in states where it is hard or impossible to get full reproductive care. millions more say those restrictions and bans go too far. by more than a two to one ratio, voters say abortion access across the country has become too difficult, rather than too easy. when put directly to the people, abortion access has largely been a winning issue. we ve seen it time and time again. but when left to state lawmakers, buffeted by the safety of their gerrymandered districts, that access has been rolled back systematically. do those truths hold? how long will abortion be a motivating issue. and are those districts really all that safe when the vast majority of women and most men say lawma
what happened in oregon in the pacific north west here is we have a very specific three-day event where we had temperatures that were 40 degrees fahrenheit above normal that led to dust, that led to extreme costs and actions the county had to take on in order to respond to that. and this heat event through scientific research has been directly tie today the impacts of climate change. this is kind of like the argument that was made against big tobacco. that was a successful argument. do you believe that this is similar enough to get the same result? yeah, i do. i mean i think that we have seen whether it s been opioid cases, whether it s been big tobacco, we have seen time and time again these companies that have been putting out disinformation lies to the public to prevent them from being held responsible for
chris. hans nickels at the white house. we appreciate it. and up next, intense negotiations are under way as the three biggest drug distributors in the country aim to settle thousands of opioid cases to the tune of tens of billions of dollars. just ahead in the start of next week s first federal trial to determine who s responsible for the nation s opioid crisis. but first, history was made today as nasa astronauts christina cook and jessica completed the first all female space walk. 248 miles above earth. that s live look at them getting unsuited after the space walk. the two replaced a power controller that failed over the weekend and in doing so, realized the dream of a lifetime for both of them. we called ourselves space sisters because we were together really joined at the at the hip going through all the classes together. jessica and i are held to the exact same training standards. we re treated the same in terms
juan: a major battle in america s opioids crisis. new york governor andrew cuomo announcing plans for a massive against drugmakers. accusing the companies of causing immeasurable damage. the governor claiming drug producers have been ripping off his state to the tune of $2 billion. other stories raising concerns. a new washington post story saying the opioid crackdown is forcing chronic pain patients to taper off them. the maker of oxycontin, purdue pharma, reportedly reaching a $12 billion agreement to settle thousands of opioid cases. dana, not only that, apparently the family uses control loses control of purdue pharma. dana: i think they probably want to lose control. i think the $12 billion settlement, looks like it would hurt a lot. it s not going to cover with the cities, states, and some of the
appropriate for these medications. now, the oklahoma trial sets the stage for dozens of other opioid cases. in this fall there will be a federal trial in ohio, bringing nearly two dozen lawsuits into one and going after the opioid makers. here with me is one of the lawyers working on the lawsuit. paul han lee. thanks for coming in. you just heard the reaction from the attorneys for johnson & johnson. what is your reaction? we hear that defense quite a lot and as the court in oklahoma found t defense does not stand up in the face of evidence concerning false marketing of these materials. the fact that the drug is approved by the fda does not give the manufacturers or distributors a license to make false statements concerning the characteristics of the drug. and that s precisely what the judge in oklahoma found. so what does this ruling mean for you as you prepare for this